The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dzhalalov S.Ch.

Westminster International University in Tashkent

Dzhalalova D.Kh.

Tashkent Pharmaceutical Institute

Krahn M.D.

University of Toronto, Canad

Hoch J.S.

University of California

Incremental vs. average cost-effectiveness ratio: which one is preferable in health technology assessment?

Authors:

Dzhalalov S.Ch., Dzhalalova D.Kh., Krahn M.D., Hoch J.S.

More about the authors

Views: 3563

Downloaded: 116


To cite this article:

Dzhalalov SCh, Dzhalalova DKh, Krahn MD, Hoch JS. Incremental vs. average cost-effectiveness ratio: which one is preferable in health technology assessment? Medical Technologies. Assessment and Choice. 2020;(3):29‑35. (In Russ.)
https://doi.org/10.17116/medtech20204103129

Recommended articles:
Economic analysis of diabetes type 1 screening in children in the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2024;(3):104-114
Is arti­ficial inte­lligence nece­ssary for healthcare system?. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):40-48
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Cost-effectiveness analysis of bariatric surgery in obese patients. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):62-75
Predictors of myocardial infa­rction in patients with stable peri­pheral artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):61-65

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.